Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Quipt Home Medical Corp

Healthcare US QIPT

NoneUSD
0.00(0%)

Last update at 2026-04-23T21:04:23.729638Z

Day Range

--
LowHigh

52 Week Range

1.354.07
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap61.26M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA43.75M
  • Revenue TTM240.85M
  • Revenue Per Share TTM5.60
  • Gross Profit TTM 173.59M
  • Diluted EPS TTM-0.21

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Income before tax -2.69900M 2.21M -9.32900M -4.05286M -6.70192M
Minority interest - - - - -
Net income -2.78400M 4.84M -6.17400M -4.18136M -6.90512M
Selling general administrative 5.28M 5.49M 47.37M 32.08M 28.96M
Selling and marketing expenses - 3.63M 2.38M 0.45M 0.47M
Gross profit 163.84M 106.65M 74.18M 52.99M 43.39M
Reconciled depreciation 40.16M 23.04M 17.79M 14.62M 10.55M
Ebit 15.09M 17.36M 2.90M 4.49M 2.83M
Ebitda 55.25M 40.40M 20.69M 19.11M 13.38M
Depreciation and amortization 40.16M 23.04M 17.79M 14.62M 10.55M
Non operating income net other - - - - -
Operating income 15.09M 17.36M 2.90M 4.49M 2.83M
Other operating expenses 206.56M 122.06M 95.72M 67.19M 57.81M
Interest expense 6.61M 2.08M 1.85M 1.85M 1.92M
Tax provision 0.09M -1.90400M -3.15500M 0.13M 0.20M
Interest income - - - 0.00000M 0.03M
Net interest income -6.60700M -2.07900M -1.99300M -2.06491M -3.22405M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.09M -1.90400M -3.15500M 0.13M 0.20M
Total revenue 221.74M 139.86M 102.35M 73.03M 61.16M
Total operating expenses 148.67M 88.85M 67.54M 47.15M 40.04M
Cost of revenue 57.90M 33.21M 28.17M 20.04M 17.77M
Total other income expense net -11.27000M -15.14400M -12.23400M -8.54351M -9.53090M
Discontinued operations - - - -1.15800M 1.75M
Net income from continuing ops -2.78400M 4.84M -6.17400M -4.18136M -6.90512M
Net income applicable to common shares - 4.84M -6.17400M -6.75500M -7.38600M
Preferred stock and other adjustments - - - - -
Breakdown 2024-09-30 2023-09-30 2022-09-30 2021-09-30 2020-09-30
Type yearly yearly yearly yearly yearly
Date 2024-09-30 2023-09-30 2022-09-30 2021-09-30 2020-09-30
Total assets 246.86M 247.41M 132.21M 108.57M 71.82M
Intangible assets 67.95M - 28.89M 14.87M 5.56M
Earning assets - - - - -
Other current assets 6.91M - 1.05M 1.43M 0.55M
Total liab 140.06M 136.29M 52.67M 49.95M 43.68M
Total stockholder equity 107.19M 111.11M 79.55M 58.62M 28.14M
Deferred long term liab - - - 0.42M 0.77M
Other current liab 6.05M - -18.67000M 5.58M 6.18M
Common stock - - 214.25M 202.83M 167.77M
Capital stock 0.00000M - 214.25M 202.83M 167.77M
Retained earnings -170.57100M - -161.02400M -165.86300M -165.92383M
Other liab - - - 0.13M 3.80M
Good will 50.73M - 28.21M 12.46M 3.88M
Other assets -0.11546M - 0.09M 0.50M 0.86M
Cash 16.17M 17.21M 8.52M 34.61M 29.12M
Cash and equivalents - - - - -
Total current liabilities 60.85M 60.57M 41.74M 32.74M 24.30M
Current deferred revenue 3.57M - 3.04M 7.34M 4.39M
Net debt 83.63M -17.20900M 18.05M -7.55800M -6.25971M
Short term debt 21.92M - 15.63M 9.97M 6.33M
Short long term debt 16.05M - 12.33M 6.99M 4.30M
Short long term debt total 99.80M - 26.56M 27.05M 22.86M
Other stockholder equity 277.76M - 26.32M 21.66M 16.32M
Property plant equipment - - 33.50M 23.51M 22.24M
Total current assets 73.05M 65.43M 41.54M 57.23M 45.12M
Long term investments 1.31M - - - -
Net tangible assets - - 22.45M 31.29M 25.03M
Short term investments - - - - -
Net receivables 29.12M 48.22M 16.38M 11.94M 9.06M
Long term debt 64.60M - 3.73M 12.30M 13.32M
Inventory 20.85M - 15.59M 9.25M 6.39M
Accounts payable 29.31M 60.57M 41.74M 9.84M 7.41M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - 9.97M
Additional paid in capital - - - - -
Common stock total equity - - - - 167.77M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.06M 128.57M 0.09M 0.50M 0.64M
Deferred long term asset charges - - - - -
Non current assets total 173.92M 181.97M 90.68M 51.34M 26.70M
Capital lease obligations 19.15M - 10.50M 7.76M 5.25M
Long term debt total - - - - -
Breakdown 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Investments -82.82500M -42.49300M -17.83800M -7.89655M 1.77M
Change to liabilities - 2.93M 0.85M 2.86M 1.24M
Total cashflows from investing activities - -42.49300M -17.83800M -10.57000M 3.94M
Net borrowings - -3.72200M -13.89300M -17.45500M -9.26300M
Total cash from financing activities 50.87M -9.85100M 3.91M 13.95M -3.82233M
Change to operating activities - 0.45M -0.85800M 0.15M -0.31500M
Net income -2.78400M 4.84M -6.17400M -5.04647M -5.57939M
Change in cash 8.69M -26.09600M 5.38M 19.52M 6.44M
Begin period cash flow 8.52M 34.61M 29.23M 9.60M 3.27M
End period cash flow 17.21M 8.52M 34.61M 29.12M 9.71M
Total cash from operating activities 40.54M 26.34M 18.69M 13.17M 8.39M
Issuance of capital stock 27.01M - 0.00000M 19.45M 3.13M
Depreciation - 23.04M 17.79M 14.62M 10.55M
Other cashflows from investing activities - - - - 4.45M
Dividends paid - - - - -
Change to inventory - -2.41900M -0.04400M -1.77131M 0.64M
Change to account receivables - -0.20100M -8.82500M -5.14284M -5.16090M
Sale purchase of stock - - - - -
Other cashflows from financing activities 63.42M 10.79M 17.80M 7.54M 9.91M
Change to netincome - -2.54400M 15.82M 10.78M 7.83M
Capital expenditures 6.79M 8.97M 5.05M 0.09M 1.36M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -1.94900M 0.76M -8.87600M -4.66098M -3.82233M
Stock based compensation - 5.49M 4.95M 0.17M 1.56M
Other non cash items 45.27M -5.88200M 14.80M 1.49M 1.39M
Free cash flow 33.75M 17.38M 13.65M 13.08M 7.03M

Peer Comparison

Sector: Healthcare Industry: Medical Distribution

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
QIPT
Quipt Home Medical Corp		 - -% - - 142.86 0.25 0.59 0.59 2.88
COR
Cencora Inc.		 -1.2 0.45% 263.64 37.46 17.70 0.19 31.84 0.20 17.10
MCK
McKesson Corporation		 2.75 0.37% 739.53 17.95 14.53 0.20 5.04 0.22 12.17
CAH
Cardinal Health Inc		 0.97 0.50% 195.85 29.48 17.92 0.20 16.07 0.22 15.67
HSIC
Henry Schein Inc		 -0.3 0.39% 75.74 24.12 14.04 0.74 2.50 0.95 13.33

Reports Covered

Stock Research & News

View All

Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers; invasive ventilation; and home medical equipment, such as stair lifts, ramps, bath safety equipment, daily living, and ambulatory, as well as home modification solutions. It also engages in the rental and sale of medical equipment and related devices. In addition, the company offers solutions that supports patients dealing with heart and pulmonary disease, sleep apnea, reduced mobility, COPD, neuromuscular disorders, obesity, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

Quipt Home Medical Corp

1019 Town Drive, Wilder, KY, United States, 41076

Key Executives

Name Title Year Born
Mr. Gregory J. Crawford Chairman, Pres & CEO NA
Mr. Hardik Mehta Chief Financial Officer NA
Mr. Jerry Kirn VP of Operations NA
Mr. David Bachelder Exec. VP of Operations NA
Mr. William Todd Zehnder Chief Strategy Officer & Investor Relations 1975
Cole Stevens VP of Corp. Devel. & VP of Investor Relations NA
Leslie Becker Exec. VP of Bus. Devel. NA
Dr. William Dana Frazier M.D. Chief Medical Officer 1958
Mr. Mark Miles VP of Information Technology NA
Mr. Thomas W. Roehrig Exec. VP of Fin. 1966

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.